Direct identification of HLA‐presented CD8 T cell epitopes from transmitted founder HIV‐1 variants

Abstract

Cytotoxic T lymphocytes (CTLs) are a critical arm of the immune response to viral infections. The activation and expansion of antigen specific CTL requires recognition of peptide antigens presented on class I major histocompatibility complex molecules (MHC-1) of infected cells. Methods to identify presented peptide antigens that do not rely on the pre-existence of antigen specific CTL are critical to the development of new vaccines. We infected activated CD4+ T cells with two HIV-1 transmitted founder (TF) isolates and used high-resolution mass spectrometry (MS) to identify HIV peptides bound on MHC-1. Using this approach, we identified 14 MHC-1 bound peptides from across the two TF isolates. Assessment of predicted binding thresholds revealed good association of the identified peptides to the shared HLA alleles between the HIV+ donors and the naïve PBMC sample with three peptides identified through peptide sequencing inducing a CD8 T-cell response (p < 0.05). Direct infection of naïve CD4 cells by HIV TF isolates and sequencing of MHC-I presented peptides by HPLC-MS/MS enables identification of novel peptides that may be missed by alternative epitope mapping strategies and can provide valuable insight in to the first peptides presented by an HIV-infected CD4 cell in the first few days post infection. K E Y W O R D Sbiomedicine, immunoproteomics, infectious diseases, mass spectrometry-LC-MS/MS, technology INTRODUCTIONThere is a growing body of evidence demonstrating the importance of cytotoxic T lymphocyte (CTL) responses in controlling HIV infection, in both natural human infection and pre-clinical animal vaccine studies. Highly functional CTL responses to specific HIV epitopes are correlated with slow disease progression in HIV-infected individuals [1, 2]. Abbreviations: LC-MS/MS, liquid chromatography-tandem mass spectrometry; TF, transmitted founder; HIV, human immunodeficiency virusThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

“…To evaluate the contribution of each virus sequence, the proteome files were assessed using an in-silico algorithm. The use of CD8 T-cell epitope prediction tools to assess predicted epitope diversity by assigning a coverage gain value to each sequence has been previously described for both HIV-1 ( 48 , 59 ) and SARS-CoV-2 ( 60 ). Whereas previously these values were used to rank each virus proteome for the coverage it provides within the sample population it would also be possible to evaluate specific virus proteomes for the coverage they offer versus a larger population.…”

Immunotherapy for Ovarian Cancer: Disappointing or Promising?

“…To address this challenge, long synthetic peptides that contain 23–45 amino acids can be utilized. These have been demonstrated to effectively enhance T cell activation and improve processing and delivery efficiency …”

“…These have been demonstrated to effectively enhance T cell activation and improve processing and delivery efficiency. 48 3.3. Personalized Vaccines.…”